Table A1.
Time windows | Medicationsa | FRb (95% CI) | FRc (95% CI) |
---|---|---|---|
Pre-ovulatory | Acetaminophen | 1.03 (0.73, 1.44) | 1.09 (0.78, 1.53) |
Aspirin | 1.04 (0.52, 2.06) | 1.02 (0.51, 2.01) | |
NSAID | 1.03 (0.73, 1.44) | 0.96 (0.68, 1.37) | |
Peri-ovulatory | Acetaminophen | 0.94 (0.66, 1.34) | 1.01 (0.71, 1.44) |
Aspirin | 1.20 (0.62, 2.29) | 1.14 (0.60, 2.16) | |
NSAID | 1.14 (0.81, 1.62) | 1.09 (0.77, 1.54) | |
Implantation | Acetaminophen | 1.15 (0.84, 1.59) | 1.27 (0.92, 1.74) |
Aspirin | 1.89 (1.10, 3.26) | 1.73 (1.01, 2.97) | |
NSAID | 1.13 (0.79, 1.64) | 1.07 (0.75, 1.51) | |
Non-Bleeding Days | Acetaminophen | 1.14 (0.90, 1.44) | 1.19 (0.94, 1.51) |
Aspirin | 1.10 (0.70, 1.75) | 1.14 (0.72, 1.80) | |
NSAID | 0.97 (0.74, 1.25) | 0.93 (0.71, 1.21) |
The reference group for each medication are cycles in which none of that medication was reported for that particular window.
Sensitivity analysis of the full model, limiting each exposure variable to cycles in which at least four days of the corresponding time window was observed in the daily diary.
Sensitivity analysis of the full model, adjusting for gravidity.